Hodgkin's lymphoma: Difference between revisions

 
(3 intermediate revisions by 2 users not shown)
Line 6: Line 6:
*Bimodal distribution: young adulthood and older aged  
*Bimodal distribution: young adulthood and older aged  
*Most common malignancy in ages 15-19 years
*Most common malignancy in ages 15-19 years
*Survival >90% in low-risk patients
*Survival >90% in low-risk patients


==Clinical Features==
==Clinical Features==
Line 14: Line 14:
==Differential Diagnosis==
==Differential Diagnosis==
{{Cervical lymphadenopathy DDX}}
{{Cervical lymphadenopathy DDX}}
{{Leuk/lymph DDX}}
{{Leuk/lymph DDX}}
{{Lymphadenitis DDX}}


==Evaluation==
==Evaluation==
Line 38: Line 38:


==References==
==References==
 
<references/>
[[Category:Heme/Onc]]
[[Category:Heme/Onc]]

Latest revision as of 21:44, 9 September 2020

Background

  • Spreads from source lymph node to adjacent nodes
  • About half of cases related to Epstein-Barr virus[1]
    • HIV is also a risk factor
  • More common in males
  • Bimodal distribution: young adulthood and older aged
  • Most common malignancy in ages 15-19 years
  • Survival >90% in low-risk patients

Clinical Features

  • Painless, firm, lymph node (usually cervical or supraclavicular)
  • "B" symptoms: fever, night sweats, weight loss

Differential Diagnosis

Cervical Lymphadenopathy

Acute Leukemia/Lymphoma

Lymphadenitis

Infectious

Non-Infectious

Evaluation

  • CXR
  • CT neck/chest/abdomen/pelvis
  • Lymph node biopsy
    • Reed-Sternberg cells next to normal lymphocytes

Management

See Also

References

  1. World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 2.4